Related Experiment Videos
The sympathetic nervous system and atherosclerosis.
T Lichtor1, H R Davis, L Johns
1Section of Neurological Surgery, University of Chicago Medical Center, Illinois.
Journal of Neurosurgery
|December 1, 1987
Summary
Surgical sympathectomy and propranolol reduced atherosclerosis progression in monkey carotid arteries and aortas. These treatments may help control arterial disease in specific areas under severe atherogenic stimuli.
Area of Science:
- Cardiovascular Science
- Medical Research
- Pharmacology
Background:
- Atherosclerosis is a significant cardiovascular disease characterized by arterial wall changes.
- Diet-induced animal models are crucial for studying atherosclerosis progression and therapeutic interventions.
- The role of the sympathetic nervous system and beta-blockers in atherosclerosis is an area of ongoing research.
Purpose of the Study:
- To investigate the effects of thoracic sympathectomy and propranolol on diet-induced atherosclerosis in rhesus monkeys.
- To evaluate morphometric and chemical changes in major arterial vessels following treatment.
- To determine the efficacy of these interventions in specific arterial beds.
Main Methods:
- Rhesus monkeys were fed an atherogenic diet for 12 months to induce atherosclerosis.
- Treatment groups received either bilateral surgical thoracic sympathectomy or propranolol (40 mg/12 hrs).
- Control group received only the atherogenic diet. Morphometric and chemical analyses of arterial walls were performed.
Main Results:
- Surgical sympathectomy significantly reduced atherosclerosis progression in carotid arteries and moderately in the thoracic aorta.
- Propranolol showed a less dramatic but noticeable reduction in atherosclerosis in carotid arteries and thoracic aorta.
- No significant differences in atherosclerosis extent or chemical composition were observed in abdominal aorta or femoral arteries.
Conclusions:
- Thoracic sympathectomy and propranolol show potential in managing atherosclerosis in specific arterial segments.
- These interventions may be beneficial in controlling atherosclerosis under severe atherogenic conditions.
- Further research is warranted to explore the mechanisms and clinical applicability of sympathectomy and beta-blockers in atherosclerosis.